Generic name |
romosozumab |
|
---|---|---|
Strength |
105 mg/1.17 mL |
|
Form |
pre-filled syringe |
Special Authority criteria |
Approval period |
---|---|
For the treatment of osteoporosis in postmenopausal women who:
AND
AND
AND
|
Up to 12 months1 |